Investigating the effects of xylazine in illegal drugs and related infections
Evaluation of the prevalence of xylazine and etiology of xylazine related invasive infections
This study is looking into how often xylazine, a drug that's showing up more in illegal drugs, is causing serious health problems like skin infections in people using these substances in St. Louis, so we can better understand the risks and help those affected.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-11137446 on NIH RePORTER |
What this research studies
This research focuses on understanding the prevalence of xylazine, a drug increasingly found in the illegal drug supply, and its connection to severe health issues such as skin infections and ulcerations. By analyzing syringe residue from the local drug supply in St. Louis, the study aims to identify which illicit drugs are contaminated with xylazine and the types of infections that arise from its use. The methodology includes mass spectrometry and microbiologic cultures to gather data on the pathogens involved and the health risks posed to users. This research seeks to provide critical insights that can inform public health responses and clinical care for affected patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who use illicit drugs that may be contaminated with xylazine and are experiencing related health complications.
Not a fit: Patients who do not use illicit drugs or are not experiencing infections related to xylazine will likely not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment of infections related to xylazine use, ultimately enhancing patient care and safety.
How similar studies have performed: While the specific investigation of xylazine in illicit drugs is relatively novel, similar research has shown that understanding drug adulteration can significantly impact public health outcomes.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Marks, Laura Renee — Washington University
- Study coordinator: Marks, Laura Renee
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.